RxDoctor Payments Data

Andrew Becker, DO

Family Medicine · Johnson City, TNNPI 1700152980

Payments from drug & device makers

$8,956in general payments, 2019–2025

Across 628 payments — averaging $14.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • GSK$926
  • Lilly USA, LLC$669
  • Novo Nordisk$656
  • Amgen$638
  • AstraZeneca$571
  • plus $4K from 44 others

What the payments were for

  • Food & beverage$8,942100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,956 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$96,261
Medicare patients
154
Services billed
3,306

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide97$98,460
JardianceEmpagliflozin64$69,440
EliquisApixaban80$62,080
MounjaroTirzepatide34$56,301
TrulicityDulaglutide44$46,175
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$35,112
XareltoRivaroxaban27$33,764
FarxigaDapagliflozin Propanediol26$23,997
QuliptaAtogepant20$23,879
MyrbetriqMirabegron31$20,633
Tresiba Flextouch U-200Insulin Degludec26$18,855
VraylarCariprazine Hcl11$14,546
JanuviaSitagliptin Phosphate12$13,113
Breo ElliptaFluticasone/Vilanterol17$12,717
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$9,603

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$669$102,47678 claims
Novo NordiskOzempic$656$98,46097 claims
Boehringer IngelheimJardiance, Tradjenta$177$76,29577 claims
PfizerEliquis$514$62,08080 claims
AbbVieQulipta, Vraylar, Linzess, Synthroid$1,602$51,97195 claims
GSKTrelegy Ellipta, Breo Ellipta$926$47,82944 claims
Johnson & JohnsonXarelto$52$33,76427 claims
AstraZenecaFarxiga$571$23,99726 claims
Astellas Pharma US IncMyrbetriq$264$20,63331 claims
MerckJanuvia$32$13,11312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →